Free Trial

Day One Biopharmaceuticals (DAWN) Insider Trading & Ownership

Day One Biopharmaceuticals logo
$12.79 +0.33 (+2.65%)
(As of 12/20/2024 05:16 PM ET)

Day One Biopharmaceuticals (NASDAQ:DAWN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$5.69 M
Get DAWN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Day One Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DAWN Insider Buying and Selling by Quarter

Day One Biopharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/10/2024Samuel C BlackmanInsiderSell30,000$13.31$399,300.00  
11/11/2024Samuel C BlackmanInsiderSell10,000$16.10$161,000.00  
11/7/2024Samuel C BlackmanInsiderSell11,245$16.03$180,257.35  
10/31/2024Samuel C BlackmanInsiderSell500$16.02$8,010.00  
9/10/2024Samuel C BlackmanInsiderSell30,000$14.22$426,600.00  
8/16/2024Adam DubowGeneral CounselSell3,202$14.00$44,828.00  
8/16/2024Charles N York IICFOSell2,633$14.00$36,862.00  
8/16/2024Jeremy BenderCEOSell10,681$14.00$149,534.00  
8/16/2024Samuel C BlackmanInsiderSell2,232$14.00$31,248.00  
7/16/2024Samuel C BlackmanInsiderSell20,000$16.01$320,200.00  
6/21/2024Saira RamasastryDirectorSell10,000$13.19$131,900.00  
5/16/2024Adam DubowGeneral CounselSell3,253$16.08$52,308.24  
5/16/2024Charles N York IICFOSell2,675$16.08$43,014.00  
5/16/2024Jeremy BenderCEOSell7,873$16.08$126,597.84  
5/16/2024Samuel C BlackmanInsiderSell2,267$16.08$36,453.36  
5/10/2024Samuel C BlackmanInsiderSell10,000$16.37$163,700.00  
5/3/2024Charles N York IICFOSell8,078$17.85$144,192.30  
5/3/2024Jeremy BenderCEOSell9,154$17.85$163,398.90  
5/1/2024Charles N York IICFOSell52,183$17.89$933,553.87  
5/1/2024Jeremy BenderCEOSell70,051$17.88$1,252,511.88  
4/18/2024Samuel C BlackmanInsiderSell10,000$16.02$160,200.00  
3/25/2024Samuel C BlackmanInsiderSell10,000$16.01$160,100.00  
2/27/2024Samuel C BlackmanInsiderSell20,000$16.11$322,200.00  
2/16/2024Adam DubowGeneral CounselSell3,242$15.25$49,440.50  
2/16/2024Charles N York IICFOSell2,666$15.25$40,656.50  
2/16/2024Jeremy BenderCEOSell7,615$15.25$116,128.75  
2/16/2024Samuel C BlackmanInsiderSell2,258$15.25$34,434.50  
(Data available from 1/1/2013 forward)

DAWN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Day One Biopharmaceuticals includes Adam Dubow, Ai Day1 Llc, Charles N York II, Jeremy Bender, Julie Papanek Grant, Michael Gladstone, Papanek Julie Grant, Saira Ramasastry, Samuel C Blackman, and Xi L.P. Canaan. Learn more on insiders at DAWN.

8.40% of Day One Biopharmaceuticals stock is owned by insiders. Learn more on DAWN's insider holdings.

The following insider purchased DAWN shares in the last 24 months: Ai Day1 Llc ($13,867,054.00).

Insiders have purchased a total of 1,153,630 DAWN shares in the last 24 months for a total of $13,867,054.00 bought.

The following insiders have sold DAWN shares in the last 24 months: Adam Dubow ($208,685.71), Charles N York II ($1,480,462.93), Jeremy Bender ($2,765,006.78), Julie Papanek Grant ($516,250.00), Saira Ramasastry ($131,900.00), and Samuel C Blackman ($3,072,983.12).

Insiders have sold a total of 479,585 Day One Biopharmaceuticals shares in the last 24 months for a total of $8,175,288.54 sold.

Day One Biopharmaceuticals Key Executives

  • Dr. Jeremy Bender M.B.A. (Age 53)
    Ph.D., CEO, President & Director
    Compensation: $900k
  • Dr. Samuel C. Blackman M.D. (Age 55)
    Ph.D., Co-Founder and Head of R&D
    Compensation: $651k
  • Mr. Charles N. York II (Age 47)
    COO, CFO & Secretary
    Compensation: $715k
    1 recent trades
  • Dr. Mike Preigh Ph.D.
    Chief of Technology Operations
  • Mr. Adam Dubow (Age 57)
    General Counsel
    1 recent trades
  • Ms. Jaa Roberson
    Chief People Officer
  • Dr. Davy Chiodin Ph.D.
    Pharm.D., Chief Development Officer
  • Ms. Lauren Merendino M.B.A. (Age 48)
    Chief Commercial Officer
  • Dr. Elly Barry M.D.
    Chief Medical Officer


This page (NASDAQ:DAWN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners